The Effect of Increased Altitude on Achieved Hematocrit and EPO Dosing in End-Stage Renal Disease

被引：0
|
作者：
Brookhart, Maurice A. [1 ]
Bradury, Brian [2 ]
Winkelmayer, Wolfgang [1 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol, Boston, MA 02115 USA
[2] Amgen Inc, Dept Epidemiol, Thousand Oaks, CA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2009年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [1] THE EFFECT OF INCREASED ALTITUDE ON RECOMBINANT ERYTHROPOIETIN (EPO) DOSING AND ACHIEVED HEMATOCRIT LEVELS IN END-STAGE RENAL DISEASE
    Brookhart, M. Alan
    Bradbury, B. D.
    Winkelmayer, W.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 : S42 - S42
  • [2] The effect of altitude on erythropoietin dosing and achieved Hematocrit levels in end-stage renal disease
    Brookhart, M. Alan
    Schneeweiss, Sebastian
    Avorn, Jerry
    Bradbury, Brian D.
    Rothman, Kenneth J.
    Mehta, Jyotsna
    Fischer, Michael
    Winkelmayer, Wolfgang
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S105 - S106
  • [3] Additive effect of TIMP-1 and iron status on erythropoietin (EPO) dosing requirements in end-stage renal disease (ESRD).
    Lightfoot, BO
    Mulloy, LL
    Wang, L
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 720A - 720A
  • [4] Effect of altitude on mortality of end-stage renal disease patients on hemodialysis in Peru
    Bravo-Jaimes, Katia
    Loescher, Viky Y.
    Canelo-Aybar, Carlos
    Rojas-Camayo, Jose
    Mejia, Christian R.
    Schult, Sandra
    Nieto, Ruben
    Singh, Kyra
    Messing, Susan
    Hinostroza, Juana
    CLINICAL KIDNEY JOURNAL, 2021, 14 (03) : 998 - 1003
  • [5] Intermittent intraperitoneal ceftazidime dosing in end-stage renal disease
    Dumler, F
    Gottschling, L
    Umstead, G
    Wilson, JM
    ASAIO JOURNAL, 1998, 44 (05) : M411 - M414
  • [6] Intermittent intraperitoneal ceftazidime dosing in end-stage renal disease
    Dumler, Francis
    Gottschling, Lisa
    Umstead, Greg
    Wilson, John M.
    ASAIO Journal, 44 (05):
  • [7] Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism
    Trunzo, Joseph A.
    McHenry, Christopher R.
    Schulak, James A.
    Wilhelm, Scott M.
    SURGERY, 2008, 144 (06) : 915 - 918
  • [8] Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis
    Teigen, Mette Maja B.
    Duffull, Stephen
    Dang, Lily
    Johnson, David W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11): : 1259 - 1267
  • [9] Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism DISCUSSION
    Haigh, Philip I.
    Trunzo, Joseph A.
    Grant, Clive
    Milas, Kresimira
    Wilhelm, Scott M.
    Clark, Orlo H.
    SURGERY, 2008, 144 (06) : 919 - 919
  • [10] Increased risk of end-stage renal disease in individuals with coeliac disease
    Welander, Adina
    Prutz, Karl-Goran
    Fored, Michael
    Ludvigsson, Jonas F.
    GUT, 2012, 61 (01) : 64 - 68
12345